FMR CORP 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:22 am Sale |
2024-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA |
FMR CORP | 16,365,664 8.000% |
-2,312,862 (-12.38%) |
Filing |
| 2024-11-12 10:34 am Sale |
2024-11-08 | 13G | Taysha Gene Therapies, Inc. TSHA |
FMR CORP | 18,678,526 9.113% |
-3,760,598 (-16.76%) |
Filing |
| 2024-02-09 09:49 am Sale |
2024-02-08 | 13G | Taysha Gene Therapies, Inc. TSHA |
FMR CORP | 22,439,124 12.002% |
-5,534,422 (-19.78%) |
Filing |
| 2023-09-11 08:23 am Purchase |
2023-09-08 | 13G | Taysha Gene Therapies, Inc. TSHA |
FMR CORP | 27,973,546 14.962% |
24,768,624 (+772.83%) |
Filing |
| 2023-02-09 12:39 pm Sale |
2023-02-09 | 13G | Taysha Gene Therapies, Inc. TSHA |
FMR CORP | 3,204,922 5.132% |
-69,635 (-2.13%) |
Filing |
| 2022-11-10 11:55 am Sale |
2022-11-09 | 13G | Taysha Gene Therapies, Inc. TSHA |
FMR CORP | 3,274,557 5.951% |
-1,005,937 (-23.50%) |
Filing |
| 2022-02-09 10:01 am Sale |
2022-02-08 | 13G | Taysha Gene Therapies, Inc. TSHA |
FMR CORP | 4,280,494 11.125% |
-1,383,721 (-24.43%) |
Filing |
| 2021-02-08 10:33 am Purchase |
2021-02-05 | 13G | Taysha Gene Therapies, Inc. TSHA |
FMR CORP | 5,664,215 14.999% |
1,456,641 (+34.62%) |
Filing |
| 2020-10-13 10:35 am Purchase |
2020-10-12 | 13G | Taysha Gene Therapies, Inc. TSHA |
FMR CORP | 4,207,574 11.374% |
4,207,574 (New Position) |
Filing |